["{\"step_by_step_thinking\": \"The provided documents do not mention lucatumumab or CD140. However, we can analyze the relevant information to determine if it's related to the question. The document about GMP-140 mentions that it binds to sialylated, fucosylated lactosaminoglycans on both myeloid and nonmyeloid cells. There is no mention of CD140 or lucatumumab in this context.\n\nThe other documents are unrelated to the question, as they discuss different topics such as tumor cells, RNA biosynthesis, tubulin binding, and storage proteins.\", \"answer_choice\": B}"]